Table 4 Assay selectivity
Sample type | Lot | NAb unspiked | NAb spiked at LPC | ||||||
|---|---|---|---|---|---|---|---|---|---|
ECL | %CV | Plate CP | Condition | ECL | %CV | Plate CP | Condition | ||
Cancer | 1 | 1113 | 2.9 | 1573 | < CP | 2745 | 7.2 | 1573 | > CP |
Cancer | 2 | 1499 | 3.5 | 1573 | < CP | 2644 | 0.1 | 1573 | > CP |
Cancer | 3 | 1917 | 0.8 | 1573 | > CP | 2949 | 5.7 | 1573 | > CP |
Cancer | 4 | 1352 | 2.1 | 1573 | < CP | 2820 | 4.9 | 1573 | > CP |
Cancer | 5 | 1389 | 9.5 | 1573 | < CP | 2390 | 6.4 | 1573 | > CP |
Cancer | 6 | 1269 | 0.8 | 1573 | < CP | 3382 | 4.9 | 1573 | > CP |
Cancer | 7 | 1005 | 1.4 | 1573 | < CP | 2402 | 4.4 | 1573 | > CP |
Cancer | 8 | 998 | 7.4 | 1573 | < CP | 2362 | 1.2 | 1573 | > CP |
Cancer | 9 | 967 | 13.8 | 1573 | < CP | 1932 | 10.7 | 1573 | > CP |
Cancer | 10 | 836 | 11.9 | 1573 | < CP | 2478 | 1.3 | 1573 | > CP |
Hemolyzed | 1 | 1071 | 12.5 | 1573 | < CP | 2308 | 4.0 | 1573 | > CP |
Hemolyzed | 2 | 1144 | 0.8 | 1573 | < CP | 2745 | 19.9 | 1573 | > CP |
Hemolyzed | 3 | 893 | 9.0 | 1573 | < CP | 1717 | 3.4 | 1573 | > CP |
Hemolyzed | 4 | 802 | 0.4 | 1573 | < CP | 2066 | 10.7 | 1573 | > CP |
Hemolyzed | 5 | 553 | 2.0 | 1573 | < CP | 691 | 6.0 | 1573 | < CP |
Lipemic | 1 | 2561 | 6.3 | 1573 | > CP | 3486 | 5.7 | 1573 | > CP |
Lipemic | 2 | 1212 | 7.3 | 1573 | < CP | 2042 | 11.1 | 1573 | > CP |
Lipemic | 3 | 813 | 1.4 | 1573 | < CP | 1652 | 5.2 | 1573 | > CP |
Lipemic | 4 | 1525 | 6.0 | 1573 | < CP | 2758 | 1.0 | 1573 | > CP |
Lipemic | 5 | 1010 | 0.8 | 1573 | < CP | 1916 | 10.6 | 1573 | > CP |